WHO Drug Information Vol. 25, No. 2, 2011

More documents

Recommendations

Info

WHO Drug Information Vol. 25, No. 2, 2011ATC/DDD ClassificationATC/DDD Classification (temporary)The following anatomical therapeutic chemical (ATC) classifications and defined dailydoses (DDDs) were agreed by the WHO International Working Group for Drug StatisticsMethodology March 2011. Comments or objections to the decisions should beforwarded to the WHO Collaborating Centre for Drug Statistics Methodology atwhocc@fhi.no. The new ATC codes and DDDs will be considered final and be includedin the January 2012 issue of the ATC index. The inclusion of a substance inthe lists does not imply any recommendation of use in medicine or pharmacy. TheWHO Collaborating Centre for Drug Statistics Methodology can be contacted throughe-mail at: whocc@fhi.no.ATC level INN/Common name ATC codeNew ATC 5th level codes:ATC name changesabirateroneafliberceptaxitinibbosutinibbrentuximab vedotincatridecacogcrizotinibdapagliflozindexlansoprazolelevomethadonelosartan and amlodipinemeloxicam, combinationsmipomersennaproxen and misoprostolpasireotideperampanelruxolitinibsipuleucel-TtafamidistelaprevirtesamorelinvemurafenibL02BX03S01LA05L01XE17L01XE14L01XC12B02BD11L01XE16A10BX09A02BC06N07BC05C09DB06M01AC56C10AX11M01AE56H01CB05N03AX22L01XE18L03AX17N07XX08J05AE11H01AC06L01XE15Previous New ATC codeAntigrowth hormones Somatostatin and analogues H01CBCalcium, combinations with Calcium, combinations withother drugs vitamin D and/or other drugs A12AXEnzyme inhibitors Aromatase inhibitors L02BG126
WHO Drug Information Vol. 25, No. 2, 2011ATC/DDD ClassificationNew DDDs:INN/common name DDD Unit Adm.R ATC codeaspoxicillin 4 g P J01CA19aztreonam 0.225 g Inhal. solution J01DF01bekanamycin 0.6 g P J01GB13carumonam 2 g P J01DF02cefbuperazone 2 g P J01DC13cefminox 4 g P J01DC12conestat alfa 3.5 TU P B06AC04desvenlafaxine 50 mg O N06AX23fingolimod 0.5 mg O L04AA27flomoxef 2 g P J01DC14histrelin 0.137 mg 1 implant H01CA03isepamicin 0.4 g P J01GB11ribostamycin 1 g P J01GB10tapentadol 0.4 g O N02AX06ticagrelor 0.18 g O B01AC24vernakalant 0.2 g P C01BG111.DDD assigned according to the total content of the implant.Herbal medicinal products*New ATC 5th level codes::NameSt. John’s WortATC codeN06AX252.Assessed and approved by regulatory authorities based on dossiers including efficacy, safety,and quality data (e.g., well-established use procedure in EU)..../...127
Page 1 and 2: WHO Drug Information Vol. 25, No. 2
Page 27: WHO Drug Information Vol. 25, No. 2
Page 79 and 80:
WHO Drug Information Vol. 25, No. 2
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
show all

WHO Drug Information Vol. 25, No. 2, 2011

Create successful ePaper yourself

Delete template?

Save as template?